SRRA NASDAQ
Sierra Oncology, Inc.
1W: +0.1%
1M: +0.4%
3M: +69.8%
1Y: +182.4%
3Y: +149.9%
5Y: +12.7%
$54.99
Last traded 2022-06-30 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$79M
-50.8% ▼
Capital Expenditures
$72K
-500.0% ▼
5Y CAGR: -19.6%
Free Cash Flow
-$79M
-50.9% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$694K
+101.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$42M | -$53M | -$88M | -$81M | -$95M |
| Depreciation & Amort. | $258K | $111K | $83K | $238K | $305K |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$342K | $1M | -$2M | $795K | $3M |
| Other Non-Cash Items | $31K | -$68K | $33M | $18M | -$39K |
| Operating Cash Flow | -$36M | -$45M | -$51M | -$52M | -$79M |
| — Investing Activities — | |||||
| Capital Expenditures | -$93K | -$118K | -$39K | -$12K | -$72K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $13K | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$80K | -$118K | -$39K | -$12K | -$72K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $28M | $51M | $93M | $9M | $80M |
| Financing Cash Flow | $28M | $51M | $93M | $9M | $80M |
| Net Change in Cash | -$9M | $6M | $41M | -$43M | $694K |
| Cash End of Period | $100M | $106M | $148M | $104M | $105M |
| Free Cash Flow | -$36M | -$45M | -$51M | -$52M | -$79M |